Is Procter & Gamble's 4% Sales Growth Target at Risk From Tariff Woes?

The Procter & Gamble Company’s PG ambition to deliver up to 4% organic sales growth in fiscal 2026 faces a tougher test as tariff-related cost pressures collide with a slowing consumer environment. Management acknowledged that tariffs remain a meaningful headwind, with roughly $500 million in higher costs before-tax included in guidance, even after some relief from exemptions on natural materials and reduced retaliatory tariffs. While this represents an improvement from earlier expectations, it still threatens to weigh on pricing flexibility and volumes.

In the first quarter of fiscal 2026, Procter & Gamble posted 2% organic sales growth, driven equally by pricing and mix, while volumes were flat. This performance keeps the company on track relative to its full-year target. However, it also highlights the challenge ahead: consumption across categories decelerated through the quarter, particularly in North America and Europe, where competitive promotions have intensified. Management warned that the fiscal second quarter is likely to be the softest of the year due to tough comparisons tied to last year’s port-strike-driven order spikes.

To defend its growth algorithm, PG is leaning heavily on productivity and restructuring. The company is targeting up to $1.5 billion in gross cost-of-goods savings through Supply Chain 3.0, overhead reductions, and portfolio streamlining, partly to offset tariffs and fund innovation and demand creation. Pricing actions, largely innovation-led, have already been implemented, but management signaled caution about pushing prices too far in a value-conscious market.

Overall, PG’s 4% organic sales growth target is not out of reach, but tariffs compress the margin for error. Execution on productivity, innovation-driven pricing and a stronger second-half rebound will be critical to keeping that target intact despite ongoing trade-related uncertainty.

Can CHD & CL Deliver on Its Growth Targets Amid Tariff Challenges?

As tariff pressures ripple through the consumer staples sector, Church & Dwight CHD and Colgate-Palmolive CL face a crucial test of whether brand strength, pricing power and execution can keep their growth targets on track.

Church & Dwight’s ability to hit its growth targets amid tariff challenges rests on strong volume-led momentum and effective mitigation. In third-quarter 2025, CHD delivered 3.4% year-over-year organic sales growth, driven by 4% volume gains, while productivity programs and targeted pricing helped offset higher manufacturing and tariff costs. With tariff headwinds reduced to about $25 million and continued brand investment, CHD appears well-positioned to sustain growth despite trade pressures.

Colgate’s ability to meet its growth targets amid tariff challenges depends on pricing discipline and productivity execution. In third-quarter 2025, CL delivered 28 consecutive quarters of organic sales growth, with pricing up 2.3%, helping offset a roughly $75-million tariff headwind and higher input costs. Ongoing productivity programs and premium innovation should support growth, though volume pressures keep execution critical.

PG’s Price Performance, Valuation & Estimates

Procter & Gamble’s shares have lost 6.7% in the past six months compared with the industry’s 10.4% decline.

From a valuation standpoint, PG trades at a forward price-to-earnings ratio of 19.99X compared with the industry’s average of 17.89X.

The Zacks Consensus Estimate for PG’s fiscal 2026 and 2027 EPS indicates year-over-year growth of 2.2% and 5.3%, respectively. The company’s EPS estimates for fiscal 2026 and 2027 have been southbound in the past seven days.

Procter & Gamble currently carries a Zacks Rank #4 (Sell).

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research